Search All News
The tiny CA2 region of the brain allows memories to influence the decision to be socially aggressive and may contribute to abnormal social behaviors associated with some mental illnesses.
An increase in mental health care is being driven by people with little or no psychological distress, while many with serious distress don’t get the care they need, Columbia researchers have found.
Columbia psychiatrists say current names for psychotropic medications adversely affect patient care and clinicians should adopt new names that do not increase stigma.
Suicidal thoughts are a normal reaction to an abnormal set of circumstances, says Columbia psychologist Ali Mattu, but the silence around suicide isolates people when they need help the most.
- June 16, 2016
In cases of complicated grief, an antidepressant is useful for treating co-occurring depressive symptoms, a new Columbia study has found.
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
- May 26, 2016
Researchers from Columbia and Finland report an association between maternal nicotine level during pregnancy and increased risk for schizophrenia in children.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.